Cautionary tales in the clinical interpretation of therapeutic trial reports.

about

Cautionary tales in the clinical interpretation of therapeutic trial reports.

Item

http://www.wikidata.org/entity/Q36278143

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Cautionary tales in the clinical interpretation of therapeutic trial reports.

@ast

Cautionary tales in the clinical interpretation of therapeutic trial reports.

@en

type

Item

label

Cautionary tales in the clinical interpretation of therapeutic trial reports.

@ast

Cautionary tales in the clinical interpretation of therapeutic trial reports.

@en

prefLabel

Cautionary tales in the clinical interpretation of therapeutic trial reports.

@ast

Cautionary tales in the clinical interpretation of therapeutic trial reports.

@en

P1476

Cautionary tales in the clinical interpretation of therapeutic trial reports.

@en

P2093

Greenberg PB

http://www.w3.org/2001/XMLSchema#string

Scott IA

http://www.w3.org/2001/XMLSchema#string

P2860

Donepezil for dementia due to Alzheimer's disease

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

Publication bias in gastroenterological research - a retrospective cohort study based on abstracts submitted to a scientific meeting

“Mini-mental state”

Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

P304

611-621

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1445-5994.2005.00929.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7558745

http://www.w3.org/2001/XMLSchema#string

P698

16207261

http://www.w3.org/2001/XMLSchema#string